eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-GLUE-Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc GLUE

‎$‎19.21-0.30(-1.54%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Price Target
32.00
Based on analysts who covered GLUE
Invest in Monte Rosa Therapeutics Inc
Today
Create an eToro account to buy GLUE stock on a secure, user-friendly, multi-asset trading platform.
Buy Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics Inc GLUE
Buy GLUE

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Monte Rosa Therapeutics Inc News

GLUE Stock Price Chart

‎-13.86‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The Monte Rosa Therapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Monte Rosa Therapeutics Inc share price today is ‎$‎19.21, reflecting a ‎-1.54‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of GLUE is ‎$‎1.46B with an average volume in the last three months of 1.58M. The stock has a P/E ratio of 62.9 and a dividend yield of 0%. With the stock’s beta sitting at 1.54
Why invest in stocks on eToro?
Start with ‎$‎50

Start with ‎$‎50

Low fees

Low fees

users worldwide

users worldwide

Across 70+ countries

Across 70+ countries

BackgroundPhone
Get Started
BackgroundPhone
GLUE Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎1.46B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎19.09 - ‎$‎20.38
52W Range
i
Shows the high and low prices of the last year.
‎$‎3.49 - ‎$‎25.67
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
1.58M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
62.9
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎181.54M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎19.21
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎0.31
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.54

How can I buy Monte Rosa Therapeutics Inc stocks?

To purchase Monte Rosa Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Monte Rosa Therapeutics Inc (GLUE) page and place an order to buy Monte Rosa Therapeutics Inc.
Buy GLUE
Looking for more information? Check out our guide on Academy.
What Is Monte Rosa Therapeutics Inc?
Monte Rosa Therapeutics, Inc. is a biotechnology company focused on discovering and developing targeted therapies tuned to the unique molecular needs of patient populations. The company operates globally, focusing on enhancing the quality of life through scientific advancements in healthcare.

Monte Rosa Therapeutics operates within the biotech industry. The company's modus operandi involves employing technology to develop novel molecular glues (MGDs). The firm has a portfolio of contributions to the healthcare sector, with scientifically driven products and services.

Add GLUE to your eToro watchlist.
CEO
Markus Warmuth, MD
Employees
134
Founded
2019
HQ
Boston, Massachusetts, US
Med Tech
NASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Monte Rosa Therapeutics Inc
Invest in Monte Rosa Therapeutics Inc
Today
Create an eToro account to buy GLUE stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of GLUE is ‎$‎19.21.
The average price target for Monte Rosa Therapeutics Inc is ‎$‎32.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Monte Rosa Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Monte Rosa Therapeutics Inc is ‎$‎1.46B
Based on 2 analysts offering recommendations for GLUE in the last 3 months, the overall consensus is .
Daily Movers
Explore the biggest stocks movers on the market.
Buy GLUE
English (UK)English (UK)Check icon
DeutschDeutsch
FrançaisFrançais
PolskiPolski
PortuguêsPortuguês
DanskDansk
SuomiSuomi
EspañolEspañol
РусскийРусский
العربيةالعربية
NederlandsNederlands
SvenskaSvenska
RomânăRomână
ItalianoItaliano
中文中文
繁體中文繁體中文
NorskNorsk
ČeštinaČeština
Tiếng ViệtTiếng Việt
ΕλληνικάΕλληνικά
Scroll to top